Order Article Reprints

Chao T-F, Chan Y-H, Tsai P-C, Lee H-F, Chang S-H, Kuo C-T, Lip GYH, Chen S-A, Yeh Y-H. Prothrombin Time-International Normalized Ratio Predicts the Outcome of Atrial Fibrillation Patients Taking Rivaroxaban. Biomedicines. 2022; 10(12):3210. https://doi.org/10.3390/biomedicines10123210

Chao, Tze-Fan, Yi-Hsin Chan, Pei-Chien Tsai, Hsin-Fu Lee, Shang-Hung Chang, Chi-Tai Kuo, Gregory Y. H. Lip, Shih-Ann Chen, and Yung-Hsin Yeh. 2022. "Prothrombin Time-International Normalized Ratio Predicts the Outcome of Atrial Fibrillation Patients Taking Rivaroxaban" Biomedicines 10, no. 12: 3210. https://doi.org/10.3390/biomedicines10123210

Chao, T.-F., Chan, Y.-H., Tsai, P.-C., Lee, H.-F., Chang, S.-H., Kuo, C.-T., Lip, G. Y. H., Chen, S.-A., & Yeh, Y.-H. (2022). Prothrombin Time-International Normalized Ratio Predicts the Outcome of Atrial Fibrillation Patients Taking Rivaroxaban. Biomedicines, 10(12), 3210. https://doi.org/10.3390/biomedicines10123210